Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 8 Antibiotic use among inpatients at five regional hospitals in Limpopo Province, stratified by the AWaRe classification

From: Antibiotic prescribing to inpatients in Limpopo, South Africa: a multicentre point-prevalence survey

Variables

AWaRe category

Access

Watch

Reserve

Total

P-value

Cramér’s V test

n

%

n

%

n

%

N

%

Hospital

Hospital A

45

70.3

18

28.1

1

1.6

64

100.0

0.110

0.135

Hospital B

76

75.3

25

24.8

101

100.0

Hospital C

58

77.3

17

22.7

75

100.0

Hospital D

60

60.6

39

39.4

99

100.0

Hospital E

53

68.8

24

31.2

 

77

100.0

Total

292

70.2

123

29.6

1

0.2

416

100.0

Ward activity

Medical

117

62.6

70

37.4

187

100.0

0.005

0.160

Surgical

133

77.8

37

21.6

1

0.6

171

100.0

ICU

42

72.4

16

27.6

58

100.0

Age group

Paediatrics

75

79.0

20

21.0

95

100.0

0.000

1.000

Adults

217

67.6

103

32.1

1

0.3

321

100.0

0.037

1.102

Prescriber type

General

200

73.0

74

27.0

274

100.0

0.102

0.080

Specialist

92

64.8

49

34.5

1

0.7

142

100.0

Indication

HAI

31

41.9

42

56.8

1

1.4

74

100.0

CAI

158

68.4

73

31.6

231

100.0

SP

53

89.3

6

10.2

59

100.0

MP

50

100.0

50

100.0

Unknown

2

100.0

2

100.0

Diagnosis

LRTI

59

56.7

45

43.3

104

100.0

SST

65

73.0

24

27.0

89

100.0

Prophy OBGY

49

92.5

4

7.6

53

100.0

Neo-MP

32

100.0

32

100.0

GI

22

91.7

2

8.3

24

100.0

  1. AWaRe Access Watch Reserve, CAI community-acquired infection, GI gastrointestinal, HAI healthcare-acquired infection, LRTI lower respiratory tract infection, MP medical prophylaxis, Neo-MP neonatal medical prophylaxis, Prophy OBGY prophylaxis obstetrics and gynaecology, SP surgical prophylaxis, SST skin and soft tissue, n frequency, N population